High Purity Nootropics Powder for Advanced Applications
Discover the potential of advanced cognitive enhancement and anti-inflammatory support with our premium nootropics powder.
Get a Quote & SampleProduct Core Value
Nootropics Powder Gts-21
This high-purity white powder, identified by CAS 148372-04-7, is a selective α7 nicotinic acetylcholine receptor agonist with significant therapeutic potential. It's formulated for fast delivery and offers over 99% purity, meeting stringent quality standards for pharmaceutical intermediate applications.
- Harness the power of a selective alpha7 nicotinic acetylcholine receptor agonist for targeted therapeutic effects.
- Explore the anti-inflammatory effects of GTS-21, crucial for managing various inflammatory conditions.
- Benefit from the neuroprotective agent for Alzheimer's research and treatment development.
- Access a reliable source for schizophrenia treatment pharmaceutical intermediates with our GTS-21 dihydrochloride.
Advantages Offered
Exceptional Purity and Quality
With a purity exceeding 99%, this nootropics powder ensures reliable and consistent results, making it ideal for sensitive research and pharmaceutical applications. Our commitment to quality assurance guarantees product integrity.
Therapeutic Inflammation Management
The ability of GTS-21 dihydrochloride to attenuate pro-inflammatory cytokine production makes it a key component in managing inflammatory diseases. This contributes to improved outcomes in conditions like sepsis and ischemia-reperfusion injury.
Neuroenhancement and Protection
As a potent alpha7 nicotinic acetylcholine receptor agonist, this compound is being investigated for its nootropic and neuroprotective effects, offering potential benefits for cognitive decline and neurological disorders.
Key Applications
Cognitive Health
The nootropic properties of GTS-21 make it a subject of interest for enhancing cognitive functions and treating age-related cognitive decline, aligning with the goals of cognitive health research.
Inflammatory Diseases
Its efficacy in attenuating inflammation makes it a valuable pharmaceutical intermediate for developing treatments for conditions characterized by inflammatory responses.
Neurological Disorders
Research into its potential for treating schizophrenia and Alzheimer's disease highlights its significance as a neuroscience pharmaceutical intermediate.
Sepsis Management
In vivo studies show significant improvements in septic animals, underscoring its role in developing therapies for sepsis-induced complications.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).